Sue has been an active member of the NIH technology transfer community since 2002, where she has facilitated the advancement of scientific endeavors through collaborations, patenting, licensing, and other means. The biomedical technology transfer program at NIH is one of the world’s largest with a portfolio that includes about 1300 active licenses, 400 of which report product sales in aggregate greater than $6B per year.
She is proud to lead a team of professionals dedicated to the advancement of science using tech transfer mechanisms, focusing on best-fit solutions to achieve positive outcomes. Prior to her current position, Sue was a technology licensing specialist and branch chief, giving her an extensive range of tech transfer experiences from multiple vantage points within the NIH infrastructure and resulting in two “Deal of Distinction” awards from the Licensing Executive Society, several NIH merit awards, and a NIH Director’s award based on her achievements.
With a Ph.D. from the Department of Chemistry at Emory University and B.S. in chemistry from the University of Delaware, Sue has a firm foundation established on which to broaden her scientific knowledge in addition to a sound framework for application of other relevant aspects, including legal, business, and policy.